Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
Completed · Not applicable
Conditions studied: Prostate Cancer
In brief
The purpose of this study is to see if eating vitamin D, omega 3 and turmeric (curcumin) slows the growth of prostate cancer in men on active surveillance.
Key facts
- Study ID
- NCT03290417
- Run by
- Case Comprehensive Cancer Center
- People needed
- 37
- Starts
- 2017-09-07
- Expected to finish
- 2019-12-20
- Last updated by the study team
- 2020-02-18
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Subjects must have the diagnosis of prostate cancer and be on active surveillance. For the purpose of this study, Active surveillance implies prostate-specific antigen (PSA)<10 ng/mL, biopsy Gleason sum </=6 with no pattern 4 or 5, cancer involvement of <33% of biopsy cores, and clinical stage T1/T2a tumor.
- Subjects must be followed at the Cleveland Clinic for active surveillance.
- Subjects must be willing to adhere to the dietary modification outlined in the protocol.
- Subjects must be willing to have prostate biopsies at the baseline, and six months after enrollment into the protocol
- Subjects must have the ability to understand and the willingness to sign a written informed consent document.
You may not qualify if…
- Subjects receiving any treatment other than AS for prostate cancer.
- Subjects not followed by the Cleveland Clinic.
- Subjects unable to adhere to the dietary modification outlined in the protocol.
Where it is running
- Cleveland Clinic, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.